You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 020717


✉ Email this page to a colleague

« Back to Dashboard


NDA 020717 describes PROVIGIL, which is a drug marketed by Cephalon and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the PROVIGIL profile page.

The generic ingredient in PROVIGIL is modafinil. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the modafinil profile page.
Summary for 020717
Tradename:PROVIGIL
Applicant:Cephalon
Ingredient:modafinil
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 020717
Suppliers and Packaging for NDA: 020717
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROVIGIL modafinil TABLET;ORAL 020717 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-925 43353-925-30 30 TABLET in 1 BOTTLE, PLASTIC (43353-925-30)
PROVIGIL modafinil TABLET;ORAL 020717 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-925 43353-925-53 60 TABLET in 1 BOTTLE, PLASTIC (43353-925-53)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 24, 1998TE:ABRLD:Yes
Patent:⤷  Try a TrialPatent Expiration:May 29, 2024Product Flag?Substance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Dec 24, 1998TE:ABRLD:Yes
Patent:⤷  Try a TrialPatent Expiration:May 29, 2024Product Flag?Substance Flag?Delist Request?

Expired US Patents for NDA 020717

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ⤷  Try a Trial ⤷  Try a Trial
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 ⤷  Try a Trial ⤷  Try a Trial
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ⤷  Try a Trial ⤷  Try a Trial
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ⤷  Try a Trial ⤷  Try a Trial
Cephalon PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.